MENU

Transforming Cell Therapy: New Report Projects Shift to Cost-Effective Manufacturing by 2035

Roots Analysis India
Overview
A new report from Roots Analysis, ‘Cell Therapy Manufacturing Market 2035,’ predicts a critical shift towards more standardized, reproducible, and cost-effective production models. This transformation is driven by the urgent need to improve patient access, reduce variability, and enable commercial-scale supply. Cytiva CEO Pierre-Alain Ruffieux underscores that addressing high costs and technical constraints through consistent and efficient manufacturing is paramount for the global scalability of life-changing cell and gene therapies.
In Depth

Background

This article provides an overview of the ‘Cell Therapy Manufacturing Market 2035’ report, a comprehensive market study published by Roots Analysis, a prominent market research firm.

Report Overview

  • Market Scope: Cell Therapy Manufacturing Market
  • Geographic Scope: Global
  • Forecast Period: Up to 2035

Key Findings

  • The market is strategically transitioning towards more standardized, reproducible, and cost-effective production models. This shift aims to address the pressing needs of improving patient access to therapies, reducing variability in production, and supporting stable commercial-scale supply.
  • Pierre-Alain Ruffieux, CEO of Cytiva, highlights that while cell and gene therapies (CGTs) offer life-changing treatments for patients, their high costs and inherent technical constraints remain significant barriers to wider access.
  • Ruffieux emphasizes that establishing more consistent, reproducible, and cost-effective manufacturing processes is absolutely essential for achieving the global scale-up of these innovative therapies.
  • The report further analyzes that technological innovations, particularly the widespread adoption of automated and closed-system manufacturing solutions, will serve as powerful drivers of substantial market growth.

About Roots Analysis

Roots Analysis is a market research and consulting firm specializing in the biotechnology, pharmaceutical, and medical device sectors. They offer detailed market analysis, competitor evaluations, and technology trend forecasts to support strategic decision-making within these industries.

Source: https://www.rootsanalysis.com/reports/cell-therapy-manufacturing/285.html

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Let's share this post !

Author of this article

Comments

To comment

TOC